RNA POLYMERASE INHIBITOR ENISAMIUM FOR TREATMENT OF MODERATE COVID-19 PATIENTS: A RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOUBLE-BLIND PHASE 3 CLINICAL TRIAL

RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial

Enisamium is an orally available therapeutic that inhibits influenza A virus and SARS-CoV-2 replication.We evaluated the clinical efficacy of enisamium treatment combined Nappy Pants with standard care in adult, hospitalized patients with moderate COVID-19 requiring external oxygen.Hospitalized patients with laboratory-confirmed SARS-CoV-2 infectio

read more

Analysis of the Antagonistic Arrangement of Pneumatic Muscles Inspired by a Biological Model of the Human Arm

Technical solutions based on biological models are the subject of research by a wide range of experts and mainly concern their mechanical use.When designing a suitable actuator, they use the physical methods of biological representatives, of which a large group consists of actuators generally referred to as artificial muscles, while another group u

read more